The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective observational study: Bevacizumab (B) use and outcomes among metastatic colorectal cancer (mCRC) patients (pts) receiving care in the outpatient community in the United States.
Eric S. Nadler
No relevant relationships to disclose
Kavita Rohidas Sail
Employment or Leadership Position - McKesson (U)
Lei Chen
No relevant relationships to disclose
Stephen F. Thompson
Employment or Leadership Position - Sanofi
Michael A. Kolodziej
Employment or Leadership Position - US Oncology